Search

Search Constraints

You searched for: Author/Creator Salvesen, Helga B.

Search Results

1. A national, prospective observational study of first recurrence after primary treatment for gynecological cancer in Norway. (24th September 2017)

2. Added Value of Estrogen Receptor, Progesterone Receptor, and L1 Cell Adhesion Molecule Expression to Histology-Based Endometrial Carcinoma Recurrence Prediction Models: An ENITEC Collaboration Study. Issue 3 (1st March 2018)

3. Added Value of Estrogen Receptor, Progesterone Receptor, and L1 Cell Adhesion Molecule Expression to Histology-Based Endometrial Carcinoma Recurrence Prediction Models: An ENITEC Collaboration Study. Issue 3 (March 2018)

4. Consortium analysis of gene and gene–folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk. Issue 10 (28th July 2014)

5. Epithelial‐Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk. Issue 8 (24th September 2015)

6. GALR1 Methylation in Vaginal Swabs Is Highly Accurate in Identifying Women With Endometrial Cancer. Issue 6 (1st July 2013)

7. Gynecologic Cancer InterGroup (GCIG) Endometrial Cancer Clinical Trials Planning Meeting: Taking Endometrial Cancer Trials Into the Translational Era. Issue 8 (1st October 2013)

8. High mRNA levels of 17β-hydroxysteroid dehydrogenase type 1 correlate with poor prognosis in endometrial cancer. (15th February 2017)

9. Molecular determinants of outcome with mammalian target of rapamycin inhibition in endometrial cancer. Issue 4 (25th October 2013)

10. Molecular determinants of outcome with mammalian target of rapamycin inhibition in endometrial cancer. Issue 4 (25th October 2013)